Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Real Time RT-PCR02:57

Real Time RT-PCR

64.4K
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
64.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Designer Dynamic DNA Nanoaggregate in Living Cell for Mitochondrial Energy Restriction.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Convergent Activation of NF-κB and STAT3 Drives Cartilage Degeneration in a Murine Model of BCG-Induced Arthritis.

ACS infectious diseases·2026
Same author

De novo-designed ribozyme-controlled riboregulator for cell-free diagnostics.

Nature communications·2026
Same author

A Spatial Coding Strategy for In Situ Visualization of RNA-Specific Glycoforms.

Analytical chemistry·2026
Same author

Deoxyribonucleic Acid Activator-Triggered Entropy-Driven Catalysis-Modulated CRISPR/Cas12a-Based Portable Biosensor for Simultaneous Detection of Multiple Pathogenic Bacteria.

ACS sensors·2026
Same author

Integration of Demethylation-Switchable Deoxyribozyme with Controllable Self-Assembly of Branched DNA Nanostructures Enables In Situ Monitoring of FTO Demethylation in Living Cells.

Analytical chemistry·2026

相关实验视频

Updated: Jan 8, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.3K

媒体:多重复合,透驱动的催化,单核酸解析的ctDNA检测.

Lijia Yuan1,2, Ting Xiao1, Jing Li1

  • 1Department of Clinical Laboratory Medicine, Southwest Hospital, Third Military Medical University, 30 Gaotanyan, Shapingba, Chongqing 400038, China.

Analytical chemistry
|December 18, 2025
PubMed
概括

一种新型的多重测定方法,MED,可以在治疗点检测循环瘤DNA (ctDNA) 的无酶,单核酸溶解检测. 这项技术提供了快速,可访问的结果,以加强癌症诊断和监测.

更多相关视频

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.9K
Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

7.7K

相关实验视频

Last Updated: Jan 8, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.3K
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

13.9K
Visual Detection of Multiple Nucleic Acids in a Capillary Array
08:56

Visual Detection of Multiple Nucleic Acids in a Capillary Array

Published on: November 15, 2017

7.7K

科学领域:

  • 生物技术是生物技术.
  • 分子诊断学 分子诊断学
  • 纳米技术 纳米技术

背景情况:

  • 循环瘤DNA (ctDNA) 的实时监测对于早期癌症检测,治疗反应评估和识别耐药性至关重要.
  • 现有的ctDNA检测方法往往缺乏对点护理应用所需的可扩展性和可访问性.
  • 对能够解决ctDNA单核酸变异的敏感测试有很大的需求.

研究的目的:

  • 为检测ctDNA开发一种多重化,单核酸分解的测定方法.
  • 为了使无酶核酸放大和ctDNA在护理点的视觉检测.
  • 评估开发的试验的诊断准确性和临床潜力.

主要方法:

  • 引入多重化,驱动的催化 (EDC) 试验,用于单核酸解析的ctDNA检测.
  • 使用涉及EDC的三重放大策略,银纳米粒子 (AgNP) 催化了Ag+释放,以及尿素酶催化尿素水解以获得色度读取结果.
  • 集成与生物活性纸和智能手机读取,用于点的护理应用.

主要成果:

  • 该MED测定表明100%的一致性与测序检测一个小组的四个ctDNAs在40个血液样本.
  • 该测试在区分癌症和非癌症样本方面取得了超过85%的准确性.
  • 综合点照顾格式提供了快速 (在45分钟内) 和可访问的结果,准确度超过70%.

结论:

  • 该MED试验提供了一个可扩展的,无酶的,单核酸解析的ctDNA检测方法.
  • 护理点格式提供了快速,多重和可访问的结果,具有显著的临床潜力.
  • 这项技术可以增强早期癌症诊断,动态监测和个性化治疗策略.